Pfizer 2026 ALK+ Metastatic NSCLC Education Grant Guide

Navigating the rapidly evolving therapeutic landscape of first-line ALK-positive metastatic non-small cell lung cancer (mNSCLC) requires continuous professional medical education. As long-term clinical data matures, healthcare providers must stay informed about survival outcomes and practical adverse event management to optimize patient care.

​To bridge existing educational gaps, Pfizer Independent Medical Education has launched a competitive grant program. This Request for Proposals (RFP) invites eligible organizations to design and execute high-quality educational initiatives targeting healthcare professionals, with a particular focus on community oncology practices. This guide provides a comprehensive overview of the application requirements, timelines, and formatting expectations for this funding cycle.

​Quick Summary Box

Opportunity Overview

​The primary objective of this grant program is to increase healthcare professional understanding and awareness of recent clinical data and practical therapy management strategies for patients with ALK-positive mNSCLC. The RFP places an emphasis on addressing the unique educational needs of community oncology workflows, where time and resource constraints often impact care delivery.

​Supported initiatives must focus on increasing clinical competence and knowledge sharing. Key focus areas include updating providers on long-term clinical outcomes (such as recent data from relevant landmark phase III trials) and optimizing oral oncolytic therapy through precise adverse event management.

​Important Note: This grant mechanism supports independent medical education. It is not intended to fund clinical research projects, nor will it consider any proposals evaluating the safety or efficacy of specific therapeutic or diagnostic agents.

​Benefits

​Approved grant applications receive substantial financial backing and structural allowances to implement their programs:

• ​Significant Funding Cap: Organizations can request up to $250,000 per project to cover direct and allowable indirect expenses.
• ​Institutional Overhead Support: Unlike many philanthropic grants, Pfizer permits institutional overhead/indirect costs, which are capped at a maximum of 28% of the total proposed project budget.
• ​Flexible Educational Formats: Grantees are given the creative freedom to design programs using a wide array of formats tailored to the target audience. Examples of acceptable formats include:
  • ​Peer-to-peer interactive case-based forums.
  • ​Short-form digital media (podcasts, brief Q&A modules, and videos) optimized for community workflows.
  • ​On-agenda educational sessions or recorded expert interviews at live medical conferences.
  • ​Online training courses, webinars, newsletters, and updated medical school or fellowship training curricula.

​Eligibility Criteria

​To successfully qualify for review under this competitive internal process, applicants must adhere to strict organizational and legal rules:

• ​Organizational Status: Only legal organizations are eligible to receive funding. Individual practitioners and independent medical practice groups that are un-affiliated with a hospital, academic institution, or professional society cannot apply.
• ​Geographic Base: The applicant organization must be physically based in the United States, and the proposed educational project must be executed within the U.S..
• ​Program Leadership: The designated project/program lead must be a direct employee or contractor of the requesting organization.
• ​Accreditation Requirement: If the proposed educational activity offers continuing education (CE/CME) credits, the requesting organization must hold the appropriate valid accreditation.
• ​Collaborative Roles: For projects involving multiple departments or distinct institutions, all participating entities must hold a relevant functional role, with the primary requesting organization maintaining the lead role.

​Eligible Healthcare Professions

​Pfizer encourages multi-disciplinary education designs that reflect real-world collaborative oncology care teams. Grant applications should target educational content for:

• ​Oncologists (with a primary focus on community-based practitioners).
• ​Oncology nurses, nurse practitioners (NPs), and physician assistants (PAs).
• ​Clinical and oncology pharmacists.
• ​Allied health providers directly involved in the clinical monitoring, care, and treatment of individuals diagnosed with ALK+ mNSCLC.

​IMG/International Applicant Considerations

​Because this specific RFP is restricted to a geographic scope within the United States, foreign-based institutions and international medical societies are ineligible to apply.

​However, International Medical Graduates (IMGs), foreign fellows, and international scientists who are currently employed as faculty, contractors, or staff at a U.S.-based medical school, hospital, or education company are fully eligible to act as the project lead. The primary requirement remains that the legal entity receiving the payment must be a U.S. organization capable of entering into a binding grant agreement with a Pfizer U.S.-based legal entity.

​Required Documents

​The project proposal must be prepared carefully according to strict technical parameters. The final proposal upload must be single-spaced, utilizing Calibri 12-point font with 1-inch margins, and must not exceed 15 pages (excluding the references section).

​The application packet must contain the following core sections:

1. ​Project Plan/Proposal or Meeting Agenda: The complete scientific and pedagogical roadmap.
2. ​Goals and Objectives: A clear statement of the overall goal and measurable learning outcomes.
3. ​Assessment of Need: A quantitative baseline summary or gap analysis using relevant patient-level data justifying the project.
4. ​Target Audience Details: Description of the primary audience, total estimated population size, and sample size.
5. ​Project Design and Methods: The specific educational approach and implementation plan.
6. ​Innovation Statement: Explanation of the project's originality and evidence that it does not duplicate existing materials.
7. ​Evaluation and Outcomes Plan: Detailed metrics and data collection methods used to analyze the project's success and audience engagement.
8. ​Dissemination Plan: A strategy for extending the benefits of the materials or resources publicly beyond the grant timeline.
9. ​Organization & Partner Details: Description of institutional attributes and the specific roles of each partner entity.
10. ​Budget Narrative: A deep, line-item justification explaining the costs submitted via the portal.

​Application Process

​Applications that fail to use the designated portal or follow exact submission settings will be automatically canceled without evaluation.

1. ​Access the Portal: Navigate

    to the designated portal at www.cybergrants.com/pfizer/knowledge. First-time users must click "Create your password" before the deadline.

2. ​Initiate Application: Click on the button labeled "Start A New Knowledge Gap Application".
3. ​Select Mandatory Metadata: In the designated fields, ensure you select the following exact parameters to route your application correctly:
   • ​Competitive Grant? Select Yes.
   • ​Primary Area of Interest: Select Oncology - Lung - KG.
   • ​Competitive Grant Program Name: Select 2026 ONC US ALK+ Metastatic NSCLC IM
4. ​Complete Forms and Upload: Fill out all online forms and upload your 15-page project proposal PDF into the "General RFP Submission" field.
5. ​Disclose AI Tool Usage: You must disclose whether any artificial intelligence (AI) tools were utilized during preparation. If applicable, briefly state the tool used, how it was applied (e.g., editing, drafting), and the validation process.
6. ​Submit: Complete all electronic verifications and submit the application package before the evening deadline.

​Tips to Increase Your Chances

• ​Focus on Adverse Event Management: Proposals that outline concrete, innovative educational strategies for managing oral oncolytic toxicities—specifically weight gain, hyperlipidemia, and neurocognitive/CNS-related effects—will stand out to the internal review board.
• ​Encourage Academic-Community Collaboration: Highlight pathways that bring expert academic center knowledge directly into community oncology practices.
• ​Include Biomarker Education: Incorporate elements that teach the critical clinical importance of appropriate, upfront biomarker testing directly to patients or care teams.
• ​Keep Budgets Realistic: While budgets up to $250,000 are allowed, Pfizer intends to support only 2 to 3 proposals total and actively encourages highly efficient proposals with smaller budgets.

​Common Mistakes to Avoid

• ​Missing the AI Disclosure: Failing to disclose the use of generative AI tools for writing, editing, or brainstorming can lead to immediate application disqualification.
• ​Including General Overhead as Line Items: Do not put basic running costs (e.g., heating, electricity, legal fees) as separate line items; these must be absorbed entirely within your 28% institutional overhead allocation.
• ​Attempting Late Submissions: The electronic portal closes automatically. Applications submitted even a minute after the deadline will be rejected without exception.
• ​Assuming Post-Award Flexibility: Grant agreement terms are fixed. Pfizer will not review modifications to the agreement post-approval unless there is an explicit conflict with local or federal laws.

​Application Timeline

​The key implementation dates for the 2026 funding cycle are detailed below: 

Deadline

​The absolute submission deadline is July 15, 2026, at 23:59 Eastern Standard Time (New York, GMT -5).

​FAQs

​Can a private physician practice group receive this grant directly?

No. Only structured organizations (such as medical schools, professional societies, healthcare institutions, or medical education companies) are eligible. Independent groups of physicians not affiliated with a hospital or academic center do not qualify.

​What happens if our institution cannot accept the payment directly?

The grant will be rescinded. Pfizer policy dictates that payments can only be made directly to the accredited grantee organization, not to individuals. Always verify your institution's funding compliance policies prior to applying.

​Can we use the grant funds to purchase specific lung cancer medications for our clinic?

No. Independent Medical Education grants awarded by Pfizer's Global Medical Grants program cannot be used to purchase therapeutic assets, prescription drugs, or non-prescription options.

​Are we allowed to exceed the 15-page limit if we include extensive data graphics?

No. The 15-page ceiling is a hard limit for the project proposal text. Only the references section is safely excluded from this count.

​Official Link(s)

• ​Pfizer Grant Submission Portal: www.cybergrants.com/pfizer/knowledge
• ​Inquiries/Grant Officer Contact: Written inquiries regarding the RFP should be directed to Sue Lee (sue.lee@pfizer.com) with the subject line "2026 ONC US ALK+ Metastatic NSCLC IME".

​Final Thoughts

​For medical education entities and academic institutions looking to make a measurable difference in community oncology, this Pfizer IME grant provides an exceptional resource. By designing programs that turn complex clinical data into actionable, front-line management strategies, your organization can directly improve how community care teams support patients fighting ALK-positive mNSCLC. Ensure your proposal remains strictly non-promotional, complies perfectly with font and page guidelines, and is routed through your institution's grant office well ahead of the July deadline.